Navigation Links
Positive Phase 2b Results with Sarilumab in Rheumatoid Arthritis to be Presented as a Late-Breaking Poster at the 2011 American College of Rheumatology Annual Meeting
Date:10/27/2011

e primary objective of the dose ranging portion of the trial was to demonstrate that sarilumab in combination with MTX is effective in reducing the signs and symptoms of RA at 12 weeks.  The five doses tested were 100 milligrams (mg) and 150 mg every week and 100 mg, 150 mg, and 200 mg every other week.  

The primary objective of the Phase 3 portion of the trial, which is currently enrolling patients, is to demonstrate that sarilumab in combination with MTX is effective in reducing the signs and symptoms of RA at 24 weeks.  The Phase 3 portion of the MOBILITY trial is evaluating two active doses of sarilumab, 150 mg and 200 mg administered every other week, compared to placebo.  Further details about the MOBILITY trial are available at http://clinicaltrials.gov/ct2/results?term=SAR+153191+mobility.

About Rheumatoid arthritisRheumatoid arthritis (RA) is a chronic systemic autoimmune disease affecting approximately 0.5%–1% of the global adult population.  Abnormal immune response causes an inflamed, thickened synovium, the membrane that lines the joint.  As synovitis expands, the inflammatory process can damage the bone and cartilage of the joint and the surrounding tissues.  RA-related inflammation can involve the heart and the lung.  In 10% of patients with RA, the liver is affected.  Complications of RA include anemia and leucopenia.  At times, RA can be very painful and affect a person's ability to carry out everyday tasks.  Most people with RA experience periods when their symptoms worsen (flares or active disease), separated by periods in which the symptoms improve.  Studies suggest that blockade of IL-6 signaling, one of several key cytokines involved in the inflammatory processes related to RA, may reduce inflammation of the joints, prevent long-term damage, and relieve certain systemic effects of RA, s
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe
2. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
3. Hydrocodone and Oxycodones Lead U.S. General Workforce Positives, Outranked Only by Marijuana, According to Quest Diagnostics Drug Testing Index™
4. Hepatitis C Phase 2A Trial Positive Results
5. Daval International Announces Positive Phase II Results for AIMSPRO® as a Monotherapy in Established Diffuse Cutaneous Systemic Sclerosis (Scleroderma)
6. Echo Therapeutics Announces Positive Results of Clinical Trial of Its Symphony® Continuous Glucose Monitoring System
7. NVA237 Filed in Europe and Positive Phase III Data at European Respiratory Society Congress
8. Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials
9. Ampio Announces Positive Results From 12-Week Open Label Extension Study of Zertane™ in Patients With Premature Ejaculation.
10. ALIMTA Receives Positive Opinion From CHMP as Continuation Maintenance Therapy for Deadly Form of Lung Cancer
11. Clermont Pharmaceuticals Reports Positive Phase III Results for Drug to Treat Glaucoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015  China Nepstar Chain ... a leading retail drugstore chain in China ... stores, today announced the resignation of Mr. Fuxiang ... personal reasons, effective immediately. Ms. Rebecca Yingnan Zhang ... the Company,s board of directors, effective immediately. Meanwhile, Ms. ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/5x377m/north_american ) has announced the addition of ... by Type (Ankle Replacement, Digit Replacement, Elbow ... - Forecast to 2019" report to ... market for knee replacement was valued at ...
(Date:5/21/2015)... CHICAGO , May 21, 2015 /PRNewswire-USNewswire/ ... lump along the side of his neck, ... and took a couple weeks off from ... didn,t go away.                               ... Rendino, 26, was referred to Michel ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... LONDON and MISSISSAUGA, Ontario, March 29, 2011 GlaxoSmithKline ... VRX ) (TSX: VRX) announced today that the European ... an adjunctive (add-on) treatment of partial onset seizures (a ... specific area in one side of the brain), with ...
... TALLAHASSEE, Fla., March 29, 2011 Public/Private Sector Strategies ... Florida Senate President Mike Haridopolos, R-Melbourne, its report detailing ... The report makes recommendations in 21 areas that conservatively ... year. "Our charge was to identify steps ...
Cached Medicine Technology:GSK and Valeant Receive European Authorisation for Trobalt (retigabine) 2GSK and Valeant Receive European Authorisation for Trobalt (retigabine) 3GSK and Valeant Receive European Authorisation for Trobalt (retigabine) 4GSK and Valeant Receive European Authorisation for Trobalt (retigabine) 5Senate Receives Rx Blueprint Plan That Reduces Spending and Increases Quality 2
(Date:5/22/2015)... A Phase 3 French study, ... of Clinical Oncology (ASCO)’s annual meeting at the ... those patients who received bevacizumab in addition to ... (Avastin® Genentech, Inc.) is an antibody that blocks ... routinely used to treat many other cancers, including ...
(Date:5/22/2015)... Wimbledon Health Partners, the leading on-site diagnostic ... NCV testing , is proud to announce the ... National athlete, to the Wimbledon Athletics division. , ... of testing and information it provides to be extremely ... this way they can focus on the task at ...
(Date:5/22/2015)... 2015 DMG Productions announces the upcoming ... broadcast on Friday, May 29, 2015 at 7:30 a.m. ... In this episode Innovations will explore Interstate Restoration, a ... quickly through disaster recovery and restoration. , Additionally, the ... collaboratively to develop and deliver training and education in ...
(Date:5/22/2015)... 2015 Ticket Down is a reputable source ... NHL Eastern Conference Finals Tickets . All seating for ... in the ticket listing. , For the first time ... top of the Eastern Conference. One of the original franchises ... ups and downs over the years, but the excitement level ...
(Date:5/22/2015)... 2015 In an effort to support ... is offering to donate $5 dollars for every maintenance ... or water softening system. Customers have their needs serviced, ... gets business; and the Special Olympics receives money. Hence ... helps over 4.4 million athletes, and boasts a myriad ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2
... of have mapped all the genes in a second type ... basic cell biology and the development of cancer.A team of ... of the charity Cancer Research UK has sequenced the genome ... genome// was mapped. ,Fifty of the 4,000 genes in ...
... in the brain responsible for imitation may be behind ,the ... searching for ,roots of empathy have now found brain regions ... network of brain regions that are involved in human imitation ... the self from others.// , ...
... for calcium flow in heart cells can help failing ... day replace mechanical-assist devices or heart transplants as an ... Dr. Roger Hajjar said many heart experts believe// that ... the elderly. Specifically, Hajjar and others hypothesized that abnormal ...
... to drought has shown there is a chemical link between ... Steven J. Neill and colleagues, from the University of the ... oxide — which facilitates erections in humans — also helps ... regulate// the plant's loss of water and keep it from ...
... researchers have identified a gene which allows the malaria ... a single-celled organism which is transmitted to humans ... evaded control efforts by building resistance to virtually all ... hoped that the new discovery will lead to a ...
... turn into every single tissue in the body has been ... could do this. Work is in the embryo stage but ... into tissues such as muscle, cartilage and brain cells, which ... Lemischka of the US's Princeton University said: "The work is ...
Cached Medicine News:Health News:Innovative yeast genome may handle Cancer Clues 2Health News:Gene treatment maintains normal Heart Beat 2
For the determination of urea nitrogen in human serum....
Intended for the quantitative determination of urea nitrogen in serum. Reaction: kinetic. Wavelength: 340 nm. Linearity: 150 mg/dL (53.4 mmol/L urea) at 37C....
Intended for the quantitative determination of total bilirubin in serum. Modified evelynmalloy method. Endpoint reaction. Wavelength: 555 nm. Linearity: 20 mg/dl (340 mol/l)...
... first microplate spectrophotometer designed specifically to run ... week. With rugged hardware, proven optical performance ... barrier of traditional spectrophotometry to obtain results ... easily read up to eight, 1 cm ...
Medicine Products: